The prophylactic use of C1 inhibitor in hereditary angioedema patients undergoing invasive surgical procedures: a retrospective study

BACKGROUND: Hereditary Angioedema (HAE) is a rare autosomal dominant condition characterized by episodic angioedema, which may be triggered by invasive procedures and surgery. C1 inhibitor (C1 INH) was approved in the United States and Canada in 2009 and 2010, respectively, for the treatment of acut...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavigan, Geneviève, Yang, William H, Santucci, Stephanie, Harrison, Rachel, Karsh, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000454/
https://www.ncbi.nlm.nih.gov/pubmed/24772176
http://dx.doi.org/10.1186/1710-1492-10-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000454/
https://www.ncbi.nlm.nih.gov/pubmed/24772176
http://dx.doi.org/10.1186/1710-1492-10-17

Ejemplares similares